Related references
Note: Only part of the references are listed.The mechanism of action of BCG therapy for bladder cancer-a current perspective
Gil Redelman-Sidi et al.
NATURE REVIEWS UROLOGY (2014)
Lessons from Cancer Immunoediting in Cutaneous Melanoma
Mariana Aris et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
MART-1-and gp100-Expressing and -Non-Expressing Melanoma Cells Are Equally Proliferative in Tumors and Clonogenic In Vitro
Mariana Aris et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Human Macrophages and Dendritic Cells Can Equally Present MART-1 Antigen to CD8+ T Cells after Phagocytosis of Gamma-Irradiated Melanoma Cells
Maria Marcela Barrio et al.
PLOS ONE (2012)
Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: parallels with lympn node stroma
Sharon Stranford et al.
FRONTIERS IN IMMUNOLOGY (2012)
Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities
Florencia Paula Madorsky-Rowdo et al.
FRONTIERS IN IMMUNOLOGY (2012)
Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy
Susanna Celli et al.
NATURE MEDICINE (2011)
Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue
Soledad Mac Keon et al.
VACCINE (2010)
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation
Vincent T. Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC:: first clinical experience and evidence of an immune response
Dominik Ruettinger et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection
I. W. Nasr et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients
Maria M. Barrio et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naive prostate cancer
JW Simons et al.
CLINICAL CANCER RESEARCH (2006)
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX (R) vaccine in advanced-stage non-small-cell lung cancer
J Nemunaitis et al.
CANCER GENE THERAPY (2006)
Share Paper
